[Protocol for the antiviral therapy of hepatitis B and D].
Gervain
Judith
J
Horváth
Gábor
G
Hunyady
Béla
B
Makara
Mihály
M
Pár
Alajos
A
Szalay
Ferenc
F
Tornai
István
I
Telegdy
László
L
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001706:Biopsy; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications; D006509:Hepatitis B / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D003699:Hepatitis D / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000175:diagnosis; D009711:Nucleotides / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D000068698:Tenofovir
D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D009711:Nucleotides; D063065:Organophosphonates; D011994:Recombinant Proteins; D019259:Lamivudine; D011092:Polyethylene Glycols; C413685:entecavir; D006147:Guanine; C053001:adefovir; D007372:Interferons; D000068698:Tenofovir; C417083:peginterferon alfa-2b; D000225:Adenine; C100416:peginterferon alfa-2a